Afatinib
- Level
- Commodity
- Parent
- 51112000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51112012This classification denotes a quinazoline and antineoplastic agent and tyrosine kinase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 41UD74L59M. European Medicines Agency schedules Afatinib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32268. As of Q4 2014, AFATINIB remains the US FDA Preferred Term for this commodity. Afatinib bears US NLM identifiers UMLS ID C1879772 and NCI Concept Code C66940. SMILES: CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4.
Same parent
Under 51112000 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.